JBMR Plus
Scope & Guideline
Elevating research at the intersection of endocrinology and sports medicine.
Introduction
Aims and Scopes
- Bone Biology and Physiology:
Research focusing on the fundamental biological processes of bone formation, remodeling, and metabolism, including studies on osteoblasts, osteoclasts, and osteocytes. - Bone Diseases and Disorders:
Investigations into various bone diseases such as osteoporosis, osteogenesis imperfecta, and hypophosphatasia, including their pathophysiology, clinical manifestations, and treatment options. - Clinical Trials and Interventions:
Reports on clinical trials assessing the efficacy and safety of pharmacological and non-pharmacological interventions for bone health, including bisphosphonates, parathyroid hormone analogs, and dietary supplements. - Imaging and Biomarkers:
Studies utilizing imaging techniques (e.g., HR-pQCT, DXA) and biomarkers to assess bone quality, density, and turnover, contributing to the understanding of fracture risk and treatment outcomes. - Genetic and Molecular Mechanisms:
Exploration of the genetic, epigenetic, and molecular pathways influencing bone health and disease, including the role of microRNAs, signaling pathways, and genetic variants. - Public Health and Epidemiology:
Research addressing public health aspects of bone health, including epidemiological studies on fracture incidence, risk factors, and the impact of lifestyle and environmental factors on bone health.
Trending and Emerging
- Microbiome and Bone Health:
Emerging studies highlight the relationship between gut microbiota and bone health, exploring how dietary components and microbiome alterations can affect bone metabolism. - Personalized Medicine in Osteoporosis:
There is an increasing focus on tailoring osteoporosis treatments based on genetic, phenotypic, and lifestyle factors, indicating a shift towards personalized approaches in managing bone diseases. - Digital Health and Osteoporosis Screening:
The integration of digital technologies and machine learning in osteoporosis risk assessment and screening is gaining traction, particularly in improving access and accuracy in clinical settings. - Inflammation and Bone Disease:
Research increasingly investigates the role of inflammatory processes in bone diseases, linking systemic inflammation to conditions like osteoporosis and osteoarthritis. - Nutritional Interventions:
A growing body of literature is examining the impact of specific dietary patterns, supplements, and functional foods on bone health, reflecting a trend towards preventive and integrative health strategies.
Declining or Waning
- Vitamin D Research:
While vitamin D is crucial for bone health, the volume of studies focusing solely on vitamin D supplementation and its direct effects on bone density has decreased, possibly due to previous extensive literature. - Traditional Osteoporosis Treatments:
Research on older treatments like estrogen replacement therapy and traditional bisphosphonates is declining, as newer therapies and combination approaches gain prominence. - Animal Models of Bone Disease:
There seems to be a reduction in studies using traditional animal models for bone disease, possibly shifting towards more clinically relevant human studies or advanced models. - Basic Science of Bone Mechanotransduction:
Research focused on the basic cellular mechanisms of how mechanical forces affect bone cells has seen less emphasis, as the field moves towards integrative approaches combining biomechanics and biology.
Similar Journals
CALCIFIED TISSUE INTERNATIONAL
Pioneering insights into the pathophysiology of calcified tissues.CALCIFIED TISSUE INTERNATIONAL is a leading peer-reviewed journal published by Springer, dedicated to advancing our understanding of calcified tissues in relation to their physiological roles, pathophysiology, and therapeutic applications. With an impressive impact factor reflective of its importance in the field, this journal performs a crucial role in disseminating high-quality research that spans multiple disciplines, including Endocrinology, Orthopedics, and Sports Medicine. The journal is highly regarded within its respective categories, achieving Q1 rankings in Orthopedics and Sports Medicine, and demonstrating its commitment to excellence in scientific inquiry. While the journal operates under a traditional subscription model, it remains accessible to researchers and practitioners who seek to stay informed on the latest advancements and innovations in the study of calcified tissues. Established in 1973, CALCIFIED TISSUE INTERNATIONAL continues to be a vital resource for researchers, healthcare professionals, and students keen on exploring the intricate relationships between calcification processes and human health.
Bone Reports
Bridging research and practice for enhanced bone health.Bone Reports is a premier, peer-reviewed journal published by Elsevier that has been committed to advancing the field of orthopedics, sports medicine, and endocrinology since its inception as an open-access journal in 2015. With an ISSN of 2352-1872, this esteemed publication seeks to disseminate high-quality research that spans a diverse array of topics related to bone health, metabolic diseases, and musculoskeletal disorders. The journal boasts an impressive impact factor, contributing significantly to its recognition, with a Q2 ranking in Orthopedics and Sports Medicine and a Q3 ranking in Endocrinology, Diabetes, and Metabolism as of 2023. This open-access model enhances accessibility and engagement, allowing researchers, professionals, and students alike to stay at the forefront of developments in these critical areas. With an emphasis on rigorous methodology and innovative findings, Bone Reports is poised to become a vital resource for anyone interested in the latest advances in bone research and clinical applications.
JOMR-Journal of Oral & Maxillofacial Research
Transforming Oral Health with Groundbreaking StudiesJOMR-Journal of Oral & Maxillofacial Research is a leading open-access journal dedicated to the dissemination of high-quality research in the field of oral and maxillofacial sciences. Published by UAB Stilus Optimus, this journal has been a vital resource for researchers, clinicians, and educators since its inception in 2010, promoting innovative findings and insights that advance our understanding of oral health and surgical procedures. With an ISSN of 2029-283X, JOMR publishes a diverse range of articles covering clinical studies, case reports, and reviews, establishing itself as an essential platform for sharing knowledge among professionals in dentistry and maxillofacial surgery. The journal's commitment to open access ensures that its cutting-edge research is freely available to a global audience, enhancing collaboration and fostering academic dialogue within the field. As an important contributor to the scholarly community, JOMR plays a crucial role in shaping future research and practice in oral and maxillofacial care.
Journal of Bone Oncology
Pioneering Discoveries in Bone MalignanciesJournal of Bone Oncology, published by ELSEVIER, is a pivotal open access journal that has been advancing the field of oncology since its inception in 2012. Focused on the intricate relationship between bone-related malignancies and therapeutic advancements, this journal addresses critical issues in bone oncology, including novel treatments, diagnostic methodologies, and translational research. With a commendable impact factor reflecting its scholarly contributions and ranking in the Q2 category of oncology journals (2023), the Journal of Bone Oncology is recognized within the top 67th percentile across Scopus rankings, showcasing its relevance and quality in the medical oncology landscape. Available in open access, the journal promotes widespread dissemination of knowledge, ensuring that researchers, professionals, and students can access groundbreaking research that informs clinical practices and enhances patient outcomes. Located in Germany and targeting a global audience, the journal’s wealth of resources serves as an essential platform for fostering collaboration and innovation in the oncology community.
JOURNAL OF CLINICAL DENSITOMETRY
Illuminating the Path of Densitometry AdvancementsJOURNAL OF CLINICAL DENSITOMETRY, published by ELSEVIER SCIENCE INC, stands as a pivotal platform for the dissemination of cutting-edge research in the fields of endocrinology, orthopedics, and radiology. With an ISSN of 1094-6950 and an E-ISSN of 1559-0747, this journal supports the academic community with vital insights and advancements in clinical densitometry since its inception in 1998. The journal is recognized within the medical community, boasting impressive rankings such as Q3 in Endocrinology, Diabetes, and Metabolism, and Q2 in both Orthopedics and Sports Medicine and Radiology, Nuclear Medicine, and Imaging for 2023. These accolades underscore its significance as a valuable resource for researchers, healthcare professionals, and students aiming to advance their knowledge and practice in these critical areas. While it is not an Open Access publication, the journal provides vital contributions to the literature, emphasizing the importance of evidence-based approaches in clinical settings.
Diabetology International
Bridging academia and practice in diabetes care.Diabetology International, published by Springer Japan KK, is a leading journal dedicated to the field of diabetes research. With an ISSN of 2190-1678 and E-ISSN of 2190-1686, this journal plays a pivotal role in disseminating innovative studies and findings that advance understanding in endocrinology, diabetes, and metabolism. Its rigorous peer-review process ensures the publication of high-quality research articles, review papers, and clinical studies, making it a valuable resource for researchers, healthcare professionals, and students. The journal is indexed in Scopus and maintains respectable rankings in its categories, standing at Q3 in Endocrinology, Diabetes and Metabolism, and Q2 in Internal Medicine as of 2023. Furthermore, the journal facilitates collaborations and promotes the exchange of ideas from its base in Tokyo, Japan, helping to bridge the gap between academia and clinical practice. As it converges through the years from 2010 to 2024, Diabetology International remains committed to addressing the evolving challenges in diabetes care and research, supporting the global community's pursuit of knowledge in this crucial field.
HORMONE AND METABOLIC RESEARCH
Unraveling the Complexities of Hormonal InfluenceHORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.
JOURNAL OF BONE AND MINERAL RESEARCH
Pioneering research at the crossroads of endocrinology and orthopedics.The Journal of Bone and Mineral Research, published by Wiley, is a leading international journal dedicated to advancing the understanding of skeletal biology and bone health since its inception in 1986. With a strong focus on the intersection of endocrinology, diabetes, metabolism, and orthopedics and sports medicine, this journal holds a prestigious Q1 ranking in both fields for 2023, highlighting its significant impact and relevance in the scientific community. The journal attracts high-quality research, as evidenced by its Scopus ranking—7th in Orthopedics and Sports Medicine and 25th in Endocrinology. This makes it a vital resource for researchers, clinicians, and students keen on exploring the intricacies of bone metabolism and disorders. While the journal operates on a subscription basis, it remains committed to disseminating pivotal research and fostering innovations that enhance bone health worldwide.
Current Opinion in Endocrinology Diabetes and Obesity
Advancing Knowledge in Endocrinology, Diabetes, and ObesityCurrent Opinion in Endocrinology, Diabetes and Obesity, published by LIPPINCOTT WILLIAMS & WILKINS, offers a critical analysis of the latest advancements and trends in the fields of endocrinology, diabetes, and obesity. With an ISSN of 1752-296X and an E-ISSN of 1752-2978, this esteemed journal provides an authoritative platform for researchers, clinicians, and healthcare professionals to stay updated on emerging research and clinical practices. Renowned for its impactful contributions, the journal holds notable rankings, including Q2 in Endocrinology and Diabetes & Metabolism, as well as a commendable Q1 in Internal Medicine, reflecting its significance in the academic community. Although currently not an open access publication, articles published from 2007 to 2024 continually enrich the discourse on pressing health issues related to endocrinology and metabolic disorders. By fostering a comprehensive understanding of the complexities within these interconnected fields, it serves as an essential resource for any professional or student engaged in health science research.
Archives of Endocrinology Metabolism
Exploring the intricacies of metabolism and endocrine health.Archives of Endocrinology Metabolism is a distinguished open-access journal dedicated to advancing the field of endocrinology and metabolism. Published by SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA, this journal has established itself as a vital platform for researchers, clinicians, and scholars since its inception in 2008. With an ISSN of 2359-3997 and E-ISSN of 2359-4292, it aims to disseminate high-quality research articles that explore the latest advancements in endocrinology, diabetes, and metabolism. As of 2023, it has achieved a commendable Q3 ranking in its field, demonstrating its relevancy and increasing visibility among peers. The journal's focus spans various sub-disciplines, including hormonal regulation, metabolic disorders, and innovative therapies, making it an essential resource for both emerging professionals and seasoned experts alike. With a rich repository of research from Brazil and beyond, Archives of Endocrinology Metabolism continuously seeks to contribute to the ongoing dialogue and collaboration within the global scientific community.